DOT1L-HES6 fusion drives androgen independent growth in prostate cancer

Authors


Abstract

image

Evidence is presented for a case of androgen receptor-negative prostate cancer driven by a DOT1L-HES6 fusion gene which directly induces overexpression and pathological activation of HES6.

Ancillary